Ernexa Therapeutics To Present At Cell & Gene Meeting On The Mesa On October 6; Says ERNA-101 IND Submission On Track For 2026
Share
Why It Matters
Ernexa will show its new medicine progress at a big science meeting. The company is still on schedule to test it in people next year.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.